China: In patients with stable pulmonary arterial hypertension (PAH), pulmonary artery denervation (PADN) was safe and improved exercise capacity, clinical outcomes, and hemodynamics during the.
A sham-controlled trial in this progressive, often debilitating disease showed patients treated with a radiofrequency device had longer 6-minute walk times and other benefits.